Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Glenmark appoints head of APIs and North America operations
8:15 AM MST | December 2, 2013 | Deepti Ramesh
Glenmark Pharmaceuticals (Mumbai, India) says it has appointed Philip Gioia as president/North America and global active pharmaceutical ingredients (APIs). Gioia will be based at Mahwah, NJ, and will report to Glenn Saldanha, chairman and managing director of Glenmark. In his role, Gioia will be responsible for the generics and branded business across North America and the sales and marketing activities of the global API business. Gioia has over 25 years experience in the US pharmaceutical industry, both in generics and branded space, Glenmark says. Gioia joins...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee